Collings A J
Diabetes Care. 1989 Jan;12(1):50-5; discussion 81-2. doi: 10.2337/diacare.12.1.50.
Since cyclamates were first introduced in the early 1950s, arguments have raged over the potential carcinogenicity of this artificial sweetener. Concern over the safety of cyclamates arises from observations that some individuals and experimental animals can metabolize cyclamate to cyclohexylamine and that cyclohexylamine has been shown to produce testicular atrophy in experimental animals. This study examines the absorption, excretion, and metabolism of cyclamate, particularly its conversion to cyclohexylamine. In addition, the potential toxicity and pharmacology of cyclohexylamine are discussed.
自20世纪50年代初甜蜜素首次被引入以来,关于这种人工甜味剂的潜在致癌性的争论就一直激烈进行着。对甜蜜素安全性的担忧源于一些观察结果,即一些个体和实验动物能够将甜蜜素代谢为环己胺,并且已证明环己胺会在实验动物中导致睾丸萎缩。本研究考察了甜蜜素的吸收、排泄和代谢情况,特别是其向环己胺的转化。此外,还讨论了环己胺的潜在毒性和药理学特性。